Creative Medical Technology Holdings, Inc. (CELZ)

NASDAQ: CELZ · Real-Time Price · USD

1.850

+0.030 (1.65%)

At close: Jan 14, 2026, 4:00 PM EST

1.880

+0.030 (1.62%)

After-hours: Jan 14, 2026, 4:08 PM EST

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Stem Cell Treatments	11.00K	Log In	Log In	Log In	Log In	Upgrade
Stem Cell Treatments Growth	22.22%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
United States	11.00K	Log In	Log In	Log In	Log In	Upgrade
United States Growth	22.22%	Log In	Log In	Log In	Log In	Upgrade